rs4846051

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005957.5(MTHFR):​c.1305C>T​(p.Phe435Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.982 in 1,613,924 control chromosomes in the GnomAD database, including 782,483 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.91 ( 64268 hom., cov: 31)
Exomes 𝑓: 0.99 ( 718215 hom. )

Consequence

MTHFR
NM_005957.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.648

Publications

46 publications found
Variant links:
Genes affected
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
MTHFR Gene-Disease associations (from GenCC):
  • homocystinuria due to methylene tetrahydrofolate reductase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 1-11794400-G-A is Benign according to our data. Variant chr1-11794400-G-A is described in ClinVar as Benign. ClinVar VariationId is 167306.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.648 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.992 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTHFRNM_005957.5 linkc.1305C>T p.Phe435Phe synonymous_variant Exon 8 of 12 ENST00000376590.9 NP_005948.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTHFRENST00000376590.9 linkc.1305C>T p.Phe435Phe synonymous_variant Exon 8 of 12 1 NM_005957.5 ENSP00000365775.3

Frequencies

GnomAD3 genomes
AF:
0.909
AC:
138182
AN:
151946
Hom.:
64232
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.689
Gnomad AMI
AF:
0.996
Gnomad AMR
AF:
0.961
Gnomad ASJ
AF:
0.984
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.946
Gnomad NFE
AF:
0.999
Gnomad OTH
AF:
0.934
GnomAD2 exomes
AF:
0.975
AC:
245131
AN:
251466
AF XY:
0.981
show subpopulations
Gnomad AFR exome
AF:
0.678
Gnomad AMR exome
AF:
0.982
Gnomad ASJ exome
AF:
0.985
Gnomad EAS exome
AF:
0.999
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
0.998
Gnomad OTH exome
AF:
0.984
GnomAD4 exome
AF:
0.990
AC:
1447325
AN:
1461860
Hom.:
718215
Cov.:
60
AF XY:
0.991
AC XY:
720967
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.682
AC:
22817
AN:
33476
American (AMR)
AF:
0.980
AC:
43815
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.987
AC:
25801
AN:
26134
East Asian (EAS)
AF:
1.00
AC:
39687
AN:
39700
South Asian (SAS)
AF:
0.999
AC:
86176
AN:
86258
European-Finnish (FIN)
AF:
1.00
AC:
53402
AN:
53402
Middle Eastern (MID)
AF:
0.984
AC:
5675
AN:
5768
European-Non Finnish (NFE)
AF:
0.999
AC:
1110944
AN:
1112002
Other (OTH)
AF:
0.977
AC:
59008
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
678
1356
2034
2712
3390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21642
43284
64926
86568
108210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.909
AC:
138275
AN:
152064
Hom.:
64268
Cov.:
31
AF XY:
0.911
AC XY:
67739
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.689
AC:
28526
AN:
41396
American (AMR)
AF:
0.961
AC:
14700
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.984
AC:
3418
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5131
AN:
5138
South Asian (SAS)
AF:
0.999
AC:
4818
AN:
4824
European-Finnish (FIN)
AF:
1.00
AC:
10618
AN:
10618
Middle Eastern (MID)
AF:
0.942
AC:
277
AN:
294
European-Non Finnish (NFE)
AF:
0.999
AC:
67906
AN:
68008
Other (OTH)
AF:
0.935
AC:
1973
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
490
980
1470
1960
2450
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
888
1776
2664
3552
4440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.967
Hom.:
246698
Bravo
AF:
0.896
Asia WGS
AF:
0.981
AC:
3411
AN:
3478
EpiCase
AF:
0.998
EpiControl
AF:
0.998

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Dec 15, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 07, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 10, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Homocystinuria due to methylene tetrahydrofolate reductase deficiency Benign:3
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
1.9
DANN
Benign
0.59
PhyloP100
0.65
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4846051; hg19: chr1-11854457; COSMIC: COSV108158800; COSMIC: COSV108158800; API